TRIPLE TRADES Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Strategies & Market Trends : TRIPLE TRADES

OPEN 6.670

+5.9%

Jan 16 9:30 AM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: yard_man who wrote (2501)	6/27/2022 5:31:37 PM
From: Tweets Boar Hog	Read Replies (1) of 4446

Biotech looks interesting, I have a first load of LABU. Was a bit early another couple days up will take care of that. I am following Novavax. Novavax is just in process of getting approval for a new Covid vaccine. They (Covid vaccines) are here to stay. Like flu shots. None of that mNRA chit. Vaccine is more traditional type. Refrigeration storage suffices. Possibly much less probability of myocarditus/pericarditus, still to be determined. Data imo looked good. Just following. Lot of potential in this one. Imo. Current opinions seem to vary in that this is a major development, or too little too late to the party. Novavax was one of the recipients of federal funding. i.e. the WARP Speed project. Seems to me it could be a pretty big deal, specially for a small co like Novavax. Especially since it is global, and refrigeration storage suffices. Tweets One might suspect that gap will get filled, bottom of gap ~ 25 bucks.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next